This is inconsistent with a previous study which indicated that IR, assessed by HOMA-IR, was not significantly associated with the risk of death or MACCEs in T2DM and ACS patients after additional adjustment for NT-proBNP [42]. The gene discussed is NPPB; the disease is type 2 diabetes mellitus.